Maintenance Notice (10:30 PM January 4 - 8:00 AM January 5, 2025 UTC): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197 | Notice of Discontinuing the Use of Password-Protected Compressed Files | Various analytical charts can be searched on each product detail page and Product Document Search (The kinds of analytical charts differ by product)
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 199875-69-9 | Product Number: A3446
N-Arachidonoyl Dopamine
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- NADA
- (5Z,8Z,11Z,14Z)-N -[2-(3,4-Dihydroxyphenyl)ethyl]-5,8,11,14-eicosatetraenamide
- (5Z,8Z,11Z,14Z)-N-(3,4-Dihydroxyphenethyl)icosa-5,8,11,14-tetraenamide
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 10MG |
₩246,100
|
15 | 15 | Contact Us |
* Please contact our distributor of SEJIN CI Co., Ltd.
if you would like to purchase TCI products. The above prices do not include freight cost, customs charge and other charges to the destination. SEJIN CI Co., Ltd. (Phone: 02-2655-2480 / email:
sales@sejinci.co.kr)
* The storage conditions are subject to change without notice.
* The storage conditions are subject to change without notice.
| Product Number | A3446 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__2__8H__4__1NO__3 = 439.64 |
| Physical State (20 deg.C) | Liquid |
| Storage Temperature | Frozen (-20°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Light Sensitive,Air Sensitive,Heat Sensitive |
| CAS RN | 199875-69-9 |
| Reaxys Registry Number | 7779367 |
| MDL Number | MFCD03412031 |
Specifications
| Appearance | Colorless to Yellow clear liquid |
| Purity(HPLC)(CAD) | min. 98.0 area% |
| NMR | confirm to structure |
Properties (reference)
| Flash point | 341 °C |
GHS
Related Laws:
Transport Information:
| H.S.code* | 2924.19-000 |
Application
N-Arachidonoyldopamine: An Endogenous Cannabinoid
N-Arachidonoyldopamine (NADA) is was first synthesized as a pharmacological tool to study the endogenous cannabinoid system (ECS).1) Later NADA and other N-acyldopamines were identified as endogenous cannabinoids in the mammalian nervous tissue.2,3) It has been reported that NADA acts as an agonist of the cannabinoid 1 (CB1) receptors.1-3) It is selective for CB1 over CB2 receptors. Furthermore, NADA also acts as an agonist of the transient receptor potential vanilloid type 1 (TRPV1) ion channel, also known as the capsaicin receptor.2,3) For your reference, the endogenous cannabinoid system (ECS) modulates neuronal and immune cell function, both of which play key roles in pain, therapeutics targeting this system hold promise as novel analgesics.3) (The product is for research purpose only.)
References
- 1) N-acyl-dopamines: novel synthetic CB1 cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo
- 2) An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors
- 3) N-arachidonoyl dopamine: a novel endocannabinoid and endovanilloid with widespread physiological and pharmacological activities (a review)
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.